Recent updates in medicinal chemistry and SAR profile of therapeutically important pyrazole hybrid analogues (2022-2025).

Pyrazole motif is a privileged heterocyclic scaffold in drug discovery owing to its conformational rigidity, hydrogen-bonding potential and favorable pharmacokinetic properties. Pyrazole analogues possess numerous pharmacological effects including anticancer, antimicrobial, antidiabetic and anti-inflammatory actions etc. Also, favorable substitution pattern in published pyrazoles works as a suitable rationale to design and develop novel pyrazolyl analogues with improved therapeutic efficacy and lesser extent of toxicity. The present review focuses on following major outcomes: 1) To emphasize keen biological potential of pyrazole-based molecules with potent antimicrobial, anticancer, anti-inflammatory, antidiabetic and many more activities; 2) To compile recent literatures (2022-2025) that are dedicated toward therapeutic potential of pyrazole or pyrazolyl hybrid analogues; 3) To explore structure-activity relationship data in order to correlate structural features of most active molecules with promising therapeutic outcomes; 4) Several series demonstrated low-micromolar to nanomolar potency corroborated by docking and ADMET predictions to underscore role of computational approaches in validating binding hypotheses. This article consolidates advances in biological evaluation and